Divi's Laboratories held its earnings conference call for Q4 FY24, reporting steady operations despite pricing pressures in the generic business segment.
Strategic investments in emer…
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.